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ABSTRACT
In this study which is part of a research project on Chagas disease (CD) among Bolivian 
immigrants in Sao Paulo, we describe socioeconomic characteristics, knowledge of CD and 
implications for acess to health care. We applied a structured questionnaire to a sample of 
472 Bolivian adults (> 18 years) living in Sao Paulo and enrolled at the Barra Funda School 
Health Center. Participants’ median age was 28.5 years, 75.0% were from the Bolivian 
department of La Paz, and >90% worked in the garment industry. Respondents had lived 
in Sao Paulo for a median of 5.8 years. Only 169 (35.8%) were familiar with CD, while 
roughly half (50.4%) had lived in natural materials houses in Bolivia, 225 (47.7%) indicated 
familiarity with the vector, 23.9% had seen the vector in their homes in Bolivia, and 6.4% 
reported having been bitten by a triatomine bug. Factors associated with awareness of CD were 
analyzed by chi square tests, and those with p values <0.25 were included in a multivariable 
logistic regression model. In the multivariable logistic regression analysis, having a relative 
with CD (OR=4.3, 95% CI=1.5-12.0), having lived in a house with mud or wood walls 
(OR=0.4, 95% CI=0.2-0.8), and having heard of the triatomine bug, or vinchuca, (OR=10.0, 
95% CI=5.1-19.5) were significantly associated with awareness of CD. This study shows a low 
familiarity with CD among Bolivian migrants living in Sao Paulo, Brazil. Raising awareness 
of the disease through specific communication strategies should be an essential component of 
public health programs to reduce the burden of CD in this and other vulnerable populations. 
KEYWORDS: Bolivian migrants. Chagas disease. Awareness. Healthcare access. Neglected 
tropical diseases. 
INTRODUCTION
Chagas disease (CD) causes a greater burden of morbimortality than any other 
parasitic infection in the Americas, yet remains one of the world’s most neglected 
diseases1. Although regional collaborations such as the Southern Cone Initiative 
have led to a tremendous progress in curbing the vector transmission2, this success 
has not been replicated in the healthcarecontext; <1% of the over 6 million people 
living with the disease in the America3 have been diagnosed and treated. The 
intense movement of human populations has been a defining feature of the past 
three decades and has profoundly impacted the epidemiology of CD, involving 
nonendemic areas including major urban centers of Latin America4,5, Europe and 
the U.S.6,7. The majority of European cases originate from Bolivia, while in the U.S. 
the highest numbers are from Mexico and Central America. Regional transnational 
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migration within Latin America has profoundly impacted 
CD epidemiology, with implications for public health 
strategies. For instance, scientific data suggest that Bolivian 
migrants in Buenos Aires may represent a group with higher 
risk for CD8. 
Migrants with CD confront unique challenges to accessing 
the healthcare system; they may possess limited economic 
resources; be excluded from local healthcare services; and 
experience difficulties communicating with providers due to 
linguistic, class and cultural barriers, as seen in Europe and 
the U.S.9,10. Despite having a higher risk for CD, immigrants 
from Latin America are typically undiagnosed and may not 
have heard of the disease11,12. In addition, providers in host 
countries are often unfamiliar with CD and not up-to-date 
with treatment recommendations13,14. These many barriers 
can prevent migrants from having timely acess to diagnosis 
and etiological treatment. 
Brazil exemplifies many of the changing dynamics in 
CD’s social and epidemiological profile. In 2006, the Pan 
American Health Organization certified the interruption of 
transmission by the main vector, Triatoma infestans15 but 
estimates suggest there are over one million people infected 
with T. cruzi2,16. Internal migration from endemic rural 
areas has made CD a public health challenge in Brazilian 
cities. Sao Paulo, the fifth largest city in the world, is also 
a major destination for transnational migration. Over 
350,000 Bolivian immigrants live in the city17 and a recent 
seroprevalence study in this population found 4.4% with 
T. cruzi infection18. Bolivians primarily migrate to Sao 
Paulo in search of job opportunities and greater economic 
stability for their families19-21. Prior research on Bolivian 
immigrants living near downtown Sao Paulo indicated 
a predominantly young population working mainly in 
garment sweatshops; the majority earning between 1-3 times 
minimum wage22.
In this study, which is part of a larger research project 
on CD among Bolivian residents in Sao Paulo, we 
describe socioeconomic characteristics, awareness of CD 
and implications for health care in a sample of Bolivian 
immigrants. The goal is to gain knowledge and insight 
for strengthening healthcare policies and the delivery of 
services to help this migrant population overcoming the 
various barriers to diagnosis and treatment of CD. 
METHODS
A cross-sectional study was carried out through the 
application of a structured questionnaire to a sample of 
472 Bolivian adults (>18 years old) living in Sao Paulo who 
were registered at the Dr. Alexandre Vranjac Escola Barra 
Funda Health Center (CSEBF is its Portuguese acronym), 
a primary care clinic which is part of the Brazilian Public 
Health System. The sample size was estimated by stratifying 
the population, considering an estimated 7% prevalence of 
Chagas disease in migrant adults and assuming a variability 
of the estimate of 20% (95% confidence interval). The 
CSEBF, located in the central part of the city, is a reference 
center for the organization of assistance and care with the 
specific aim of guaranteeing healthcare access for this 
population23, providing free primary healthcare services 
to individuals regardless of their immigration status. 
From July to November 2013, participants were recruited 
while attending appointments at the CSEBF for various 
reasons. Participants who agreed to participate in the 
study underwent an informed consent process in Spanish. 
Roughly 95% of the patients who were approached agreed 
to participate.
The questionnaire was pre-tested and validated, being 
applied by professionals duly trained for this purpose 
and fluent in the Spanish language. The investigators 
created and used a Spanish-language questionnaire with 
multiple choice questions on sex, age, time living in Sao 
Paulo, education, income, employment situation and other 
socioeconomic variables. Participants were also asked about 
familiarity with the “vinchuca” (the common name for the 
triatomine bug vector in Bolivia) and with CD, including 
its transmission and symptoms. Other questions focused on 
risk factors for CD and women of childbearing age were 
asked on theaccess to Brazilian maternal/reproductive 
health services. After asking for the patients’ consent, 
Spanish-speaking interviewers applied the questionnaire 
and checked to ensure the respondents’ comprehension. 
All the participants were tested for CD.
Questionnaire data were coded and stored in a database 
for subsequent analysis. Statistical analyses were performed 
using the Epidat v. 3.5.1 (Dirección Xeral de Saúde 
Pública, Galicia, Spain) and the SPSS v. 25.0. (IBM, 
Armonk, NY, USA). In an initial univariate analysis, we 
calculated proportions and used chi-square tests to identify 
factors associated with the awareness of CD; p≤ 0.05 was 
considered significant. We then used a multivariable logistic 
regression model, including variables with a p value less 
than 0.25 in the univariate analysis24, to identify variables 
independently associated with the knowledge of CD.
The study is part of a larger research project entitled 
“Chagas disease in the Bolivian population of Sao Paulo: 
an analysis of prevalence of Trypanosoma cruzi infection, 
morbidity, knowledge, and access to healthcare”, which 
was financed by the National Council for Scientific and 
Technological Development-Department of Science and 
Technology CNPq/ DECIT, Ministry of Health, Brazil 
(grant Nº 404336/2012). The Ethics approval was given 
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by the Committee of Ethics in Research from the Clinical 
Hospital of the School of Medicine of the University of Sao 
Paulo (Nº 196.698/2013), and written informed consent was 
requested from all the participants.
RESULTS
There were slightly more females (n=255, 54%) than 
males (n=217, 46%), and more than half of the respondents 
fell into the 18-29 age range, while <15% (n=67) were over 
40. Three quarters of the respondents (n=358) were born in 
the Bolivian department of La Paz (Table 1). The median 
age was 28.5, and participants had lived in Sao Paulo for a 
median of 5.8 years. Most respondents (n=252, 53.4%) had 
lived in Sao Paulo between 1-5 years, though 209 (44.3%) 
indicated >5 years’ residence. Two thirds of the respondents 
(n=320) had completed a high school education, though 
only 22 had continued to college. Nearly all the respondents 
(99.0%) lived in two neighborhoods, Bom Retiro and Barra 
Funda. Over 90% (n=428) worked in the garment industry. 
While 102 participants (21.6%) reported a per-person family 
income of less than 678 BR or 299 US dollars, which was 
the minimum wage at the time25, 250 (52.9%) earned 
between 1-2 times the minimum wage. Neither the time 
living in Sao Paulo nor the education level were associated 
with significant differences in the income. 
Nearly half (n=225, 47.7%) of the participants indicated 
familiarity with the triatomine vector (“vinchuca”); 
106 (22.5%) had seen the vinchuca in their homes in 
Bolivia, and 30 (6.4%) recalled being bitten by a triatomine. 
In Bolivia, 277 participants (58/7%) had lived in the 
rural area and 209 (44.3%) had worked in the rural area. 
Additionally, slightly over half of the respondents (n=238, 
50.4%) had lived in houses made of natural materials (mud 
or wood). When asked if they knew what CD is, only 169 
participants (35.8%) responded affirmatively. Of these, 
119 (70.4%) claimed that the disease was transmitted by a 
triatomine insect (known in Bolivia as the vinchuca), but 
only 26 (15.4%) recognized the “enlargement of the heart” 
as a potential sign of CD. 
We assessed the awareness of CD and its association 
with demographic variables and known risk factors 
(Table 2). Male gender, being born outside the department 
of La Paz, having a relative with CD, not having lived 
in a house with mud or wood walls, having heard of the 
vinchuca, and having seen or been bitten by a vinchuca 
were all significantly associated with the awareness of CD 
in the univariate analysis. We included all the variables with 
a p value <0.25 in the univariate analysis in a multivariable 
logistic regression model (Table 3). Having a relative with 
CD (OR=4.3; 95% CI=1.5-12.0 p=0.006), having lived in a 
Table 1 - Sociodemographic characteristics of participants 
(N=472), study of Chagas disease (CD) awareness among 
Bolivian migrants in Sao Paulo.
Category N %
Sex
     M 217 45.9
     F 255 54.1
Age group (years)
     18 – 29 251 53.2
     30 – 39 154 32.6
     > 40 67 14.2
Residence in São Paulo (years)
     < 1 11 2.3
     1 – 5 252 53.4
     > 5 209 44.3
Lives with
     Family 216 45.8
     Relatives 135 28.6
     Friends 106 22.4
     Other 15 3.2
Marital status
     Single 143 30.2
     Married 155 32.8
     Stable relationship 161 34.1
     Other 13 2.9
Occupation
     Garment industry 428 90.6
     Other 44 9.4
Family income
     ≤ 1 minimum salary 102 21.6
     1-2 times the minimum salary 250 52.9
     >2 times the minimum salary 120 25.5
Education level
     Primary or less 15 3.2
     Some secondary 137 29.0
     High school graduate 298 63.1
     College 22 4.7
Risk factors to CD
     Recalls being bitten by a “vinchuca” 30 6.4
     Recalls vinchucas in the home 106 22.5
     Lived in a house of mud or wood 238 50.4
     Has a relative with Chagas disease 48 11.7
     Lived in a rural area of Bolivia 277 58.7
     Worked in a rural area of Bolivia 209 44.3
Chagas disease awareness
     Knows the vector (“vinchuca”) 225 47.7
     Knows of Chagas disease 169 35.8
     Transmitted by triatomines (“vinchucas”) 119 70.4*
     May cause enlargement of the heart 26 15.4*
*percentage within those who know about Chagas disease 
(n=169)
Silva et al.
Rev Inst Med Trop São Paulo. 2020;62:e39Page 4 of 9
Table 2 - Awareness of Chagas disease (CD) in  Bolivian migrants in Sao Paulo.
Variable
Aware of CD 
(N=169) 
N (%)
Not aware of CD 
(N=303)
% aware in 
category




     female 78/169 (46.2) 177/303 (58.4) 30.6 0.61 (0.42-0.89) 0.010
     male 91/169 (53.8) 126/303 (41.6) 41.9
Age (years)
     ≥30 87/169 (51.5) 134/303 (44.2) 39.4 1.34 (0.92-1.95) 0.130
     <30 82/169 (48.5) 169/303 (55.8) 32.7
Department of birth
     La Paz 109/169 (64.5) 249/303 (82.2) 30.4 0.39 (0.26-0.61) <0.001
     other 60/169 (35.5) 54/303 (17.8) 52.6
Education
     high school graduate 123/169 (72.8) 197/303 (65.0) 38.4 1.44 (0.952-2.17) 0.083
     <high school 46/169 (27.2) 106/303 (35.0) 30.3
Lived in rural Bolivia*
     Yes 100/169 (59.2) 177/299 (59.2) 36.1 1.01 (0.69-1.49) 0.945
     No 69/169 (40.8) 122/299 (40.8) 35.8
Worked in rural Bolivia*
     Yes 74/164 (45.1) 135/299 (45.2) 35.4 1.00 (0.68-1.47) 0.995
     No 90/164 (54.9) 164/299 (54.8) 35.4
Have a relative with CD 
     Yes 36/169 (21.3) 13/303 (4.3) 72.9 5.23 (2.67-10.25) <0.001
     No 123/169 (72.8) 239/303 (78.9) 34.0
     Don’t know 10/169 (5.9) 51/303 (16.8) 17.7
Received a blood transfusion
     Yes 11/169 (6.5) 16/303 (5.3) 40.7 1.25 (0.57-2.76) 0.582
     No 158/169 (93.5) 287/303 (94.7) 35.5
Type of housing in Bolivia
     Mud or wood 71/169 (42.0) 167/303 (55.1) 29.8 0.59 (0.40-0.86) 0.006
     Brick/cement 98/169 (58.0) 136/303 (44.9) 41.9
Knows the triatomine vector (vinchuca)
     Yes 140/169 (82.8) 85/303 (28.1) 62.2 12.38 (7.72-19.85) <0.001
     No 29/169 (17.2) 218/303 (71.9) 11.7
Saw a triatomine in the home
     Yes 71/169 (42.0) 35/303 (11.6) 67.0 5.55 (3.48-8.84) <0.001
     No 85/169 (50.3)) 185/303 (61.0) 31.5
     Don’t know 13/169 (7.7) 83/303 (27.4) 13.5
Remembers being bitten by a vinchuca
     Yes 21/169 (12.4) 9/303 (3.0) 70.0 4.00 (1.77-9.06) <0.001
     No 105/169 (62.2) 180/303 (59.4) 36.8
     Don’t know 43/169 (25.4) 114/303 (37.6) 27.4
Went hunting in Bolivia
     Yes 56/169 (33.1) 119/303 (39.3) 32.0 0.77 (0.52-1.14) 0.186
     No 113/169 (66.9) 184/303 (60.7) 38.0
Handled game in Bolivia
     Yes 63/169 (37.3) 126/303 (41.6) 33.3 0.84 (0.57-1.23) 0.360
     No 106/169 (62.7) 177/303 (58.4) 37.5
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house with mud or wood walls (OR=0.4; 95% CI=0.2-0.8, 
p=0.005), and having heard of the triatomine vector 
(“vinchuca”) (OR=10; 95% CI=5.1-19.5, p<0.001) were 
significantly associated with the awareness of CD (Table 3). 
Nineteen of twenty-five participants with positive 
serology for T. cruzi were female; the total CD prevalence 
in this sample was 5.3%. Four of the seropositive individuals 
had previously donated blood (two in Bolivia, one in Brazil, 
and one did not indicatethe place), whereas one had received 
a blood transfusion. Of the 255 females in the sample, 
only 31 (12.2%) were 40 or older, 246 (96.5%) were of 
childbearing age (10-49 years old) and 199 (78%) had 
children. While 73.7% of the mothers had received prenatal 
care (71.8% in Brazil and 26.6% in Bolivia), in only 5.3% 
of these cases the CD testing was included, and only 1.5% 
informed that their infants had been tested for CD. Of the 
women who had had prenatalcare, >90% were aware of 
and had used the Brazilian Unified Health System (SUS) 
for this service; 1.5% had coverage of private insurances 
and 2.6% paid for medical care. 
DISCUSSION
The epidemiology of CD in the twenty first century 
has been framed in part by the social and economic forces 
driving globalization4,5. Our study provides insight on 
South-South migration, which has important implications 
for the distribution of CD and access to healthcare. Of note, 
awareness of CD in at-risk populations and its importance for 
health care have rarely been considered in Brazil. The majority 
of respondents were not familiar with CD. Nonetheless, the 
prevalence of CD in the sample was 5.3%, and many had been 
exposed to risk factors including triatomines and/or housing 
susceptible to triatomine infestation, as was discussed in 
an earlier report18. In our study, the multivariable analysis 
indicated a significantly lower awareness among people who 
had lived in houses with mud or wood walls. Nonetheless, 
this group may be at higher risk for CD. A study in Santa 
Cruz, Bolivia documented a higher risk for CD26 among 
patients with cardiomyopathy who had lived in houses with 
mud or wood walls. In our study, patients with a history 
of residing in houses of mud or wood may have had lower 
access to health information and education on CD, resulting 
in a lower awareness. 
Salm and Gertsch surveyed 480 participants from 
different regions of Bolivia, members of indigenous 
groups (the majority from Ayoreo, Guarani, Quechua, and 
Chiquitano communities), while 31.4% were from major 
cities (La Paz and Santa Cruz de La Sierra). In these urban 
centers, the distribution by sex and age and the educational 
level were similar to our sample. The authors found that 
88.5% of all the participants were familiar with CD, 
although awareness was the lowest among respondents 
from La Paz (74.2%)27. The authors have also indicated 
that Quechua and Ayoreo respondents were less familiar 
with transmission routes than Guarani and Chiquitano 
participants. In our study, knowledge of the vector was the 
strongest predictor of knowledge of CD. Similarly, Salm and 
Gertsch found that awareness of CD was strongly associated 
with the vector in Bolivia.
Other studies have noted varying levels of CD 
awareness among different immigrant populations. 
Ramos et al.28 colleagues found that 63% of Bolivian 
immigrants in a sample in Elche, Spain, had heard of 
CD. In another study in Valencia, Spain, of 96 Bolivian 
immigrants, 73 (76%) had some awareness of CD, and 
most recognized that CD has an asymptomatic phase29. In 
a sample of 43 Bolivians in Munich, Germany, 30 (69.8%) 
indicated they had previously received information 
about CD, but the majority considered they had limited 
familiarity with transmission and symptoms, and >90% 
had not been previously tested30.
Bolivians in our sample exhibited lower familiarity with 
CD than in these studies. This could be explained by the 
respondents’ relative youth, perhaps because the household 
vector transmission in many parts of Bolivia was under 
control early in the millenia31. By comparison, knowledge 
of CD was significantly higher in older individuals among 
Bolivians in Valencia29. Another possibility is that the bulk 
of respondents in our study were from La Paz, which has 
lower levels of CD compared to other departments and 
was certified free of domiciliary vector transmission by 
Triatoma infestans32. 
Table 3 - Multivariable logistic regression of factors associated 







Female sex 0.7 (0.4-1.3) 0.284
Age >30 years 1.7 (0.9-3.1) 0.100
High school education 1.0 (0.5-2.0) 0.954
Relative with Chagas disease 4.3 (1.5-12.0) 0.006
Born in La Paz 1.0 (0.5-2.2) 0.970
Lived in a mud or wood house 0.4 (0.2-0.8) 0.005
Went hunting 0.7 (0.3-1.3) 0.250
Recalls triatomine in home 0.7 (0.4-1.2) 0.170
Recalls triatomine bite 1.5 (0.5-4.2) 0.452
Has heard of the triatomine vector 10.0 (5.1-19.5) <0.001
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Awareness appears to be lower in North American 
migrants. In a sample of Latin American immigrants in 
Los Angeles, most of whom were from Mexico and Central 
America, only 14% had previously heard of CD11. Similarly, 
in a sample of migrants at the Guatemala-Mexico border, 
80% had not previously heard of CD12. 
Twenty-five participants had positive serology for 
T. cruzi, as was reported in a previous article18, which 
found that seropositive respondents were significantly 
more likely to have knowledge of CD and the vector. Most 
testing positive were females, yet only 5.3% of mothers 
had received CD testing as part of their prenatal care. 
Four of the seropositive individuals indicated they had 
previously donated blood, whereas one had received a 
blood transfusion. Of the four donors, two indicated they 
had given blood in Bolivia and one in Brazil (the fourth did 
not specify the location). 
Importantly, low awareness is one of numerous barriers 
impacting the access to diagnosis and treatment for 
immigrants and other groups afflicted by CD. Awareness 
can only be understood and addressed in terms of its 
interrelationship with socioeconomic inequalities, gaps 
in the public health response to CD (often a function of 
political decisions impacting public funding and concerning 
the populations and health issues to be prioritized), and 
navigation of cultural and linguistic differences. Farmer33 
points out that entrenched global political and economic 
structures largely shape the disease epidemiology; vulnerable 
groups who bear the heaviest burden and also have the least 
access to healthcare resources and the strongest limitations 
on their agency. Sao Paulo has attracted large numbers of 
migrants in search of employment; this population faces 
significant barriers to accessing healthcare34-36. Bolivians 
in Sao Paulo are primarily young, and while most have 
attained a high school education, their income level remains 
low. Concentrated in Sao Paulo’s garment industry, they 
often confront difficult living and working conditions35,36, 
which exacerbate health risks, especially for tuberculosis 
and other infectious diseases34. Moreover, awareness of 
CD is also a key concern within the local health system; 
vector transmission was interrupted in the Sao Paulo State 
in the late 1960s15,37, and many providers in the SUS are 
unfamiliar with CD38. While Bolivians are a population at 
particular risk of CD, systematic screening, even for women 
during prenatal care, is not widely implemented. In our 
study, only 5.3% of women received CD screening as part of 
their prenatal care, which represents a missed opportunity to 
halt the vertical transmission and prevent a lifelong disease. 
Furthermore, the bulk of our sample was under the age of 
40, and could therefore still benefit, if seropositive, from a 
timely etiological treatment to prevent future complications 
of chronic CD. Such treatment also acts as an effective 
means of eliminating the vertical transmission8,39,40.
Our study has some limitations. The individuals 
interviewed were attending the CSEBF, and may not reflect 
the wider Bolivian community in Sao Paulo or elsewhere in 
Brazil, in particular those individuals who do not frequently 
attend healthcare services. The CSEBF has a history of 
working with the Bolivian community and has developed 
expertise in the health needs of this population, but this 
could have influenced respondents’ perceptions regarding 
the healthcare access in Brazil. Additionally, we only asked 
respondents if they knew about Chagas disease and certain 
aspects of its etiology and symptomology. Our study largely 
does not assess whether patient concepts of the disease differ 
from the biomedical model. A prior research in Bolivia 
suggests people with CD essentially adopt a biomedical 
understanding of the disease, but may use alternative 
approaches to treatment, including ethnomedical remedies41. 
Another potential bias is that because our sample consisted 
of migrants predominantly under the age of 40, it might be 
healthier than the population at large and potentially less 
concerned about CD, whose chronic symptoms are usually 
observed in indviduals older than 3042.
Our study, possibly the first to assess CD knowledge 
among a transational migrant population in Brazil, indicates 
that the awareness of CD in this at-risk group is low. This, 
in combination with limited discussion of CD in education 
campaigns or mass media, serves to suppress patient-driven 
demand for screening, underscoring the importance of 
both, more intensive CD awareness initiatives directed 
toward this population, and proactive screening initiated 
by providers. Simply “getting to know” about CD does 
not always translate into increased demand for testing and 
treatment, as people in endemic areas with difficult access 
to healthcare have often adapted a strategy of normalizing or 
naturalizing the existence of CD as a coping strategy27,43,44. 
Therefore, awareness campaigns need to be linked with a 
broader framework of actions to improve healthcare access 
for people at risk of CD. 
Recent policy developments in Brazil reinforce the 
need to develop strong communication strategies to 
raise awareness of CD in vulnerable groups45. A Clinical 
Protocol for Diagnosis and Treatment of CD, approved in 
late 201846, provides a specific framework for screening, 
diagnosing and treating patients, and a national policy of 
official reporting of chronic CD cases, enacted in early 
2020, should serve to reinforce epidemiological surveillance 
and follow-up of patients. Our study also suggests that 
familiarity with the vector or with the disease (when it 
affects relatives) are important drivers of CD awareness 
within this sample. Education campaigns to improve 
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awareness of CD, which are culturally and linguistically 
tailored to the Bolivian population of Sao Paulo, should 
be accompanied by intensified training and capacitation of 
primary care personnel at facilities which see large numbers 
of Bolivian patients. 
Diagnosis of CD can be emotionally devastating and 
may entail stigmatization or anxiety, which can actually 
discourage patients from seeking testing. Ideally, healthcare 
for CD should use a holistic approach, addressing not 
only the disease, but its social determinants and emotional 
consequences39. Finally, care should be taken to heighten 
awareness in a way that does not create an unfavorable 
image or contribute to stigmatization of Bolivians and/or 
immigrants. 
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